Esfahani Neda Zarghami, Anderson Daniel M, Pieper Connie, Adams Harold P
Department of Neurology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, United States.
eNeurologicalSci. 2017 Sep 1;9:1-2. doi: 10.1016/j.ensci.2017.08.004. eCollection 2017 Dec.
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are rare diseases characterized by a necrotizing small-vessel vasculitis and circulating ANCA that comprise granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (EGPA). Acute ischemic stroke (AIS) can be a manifestation of central nervous system (CNS) involvement in these diseases. Furthermore, intracerebral hemorrhage (ICH) is a potential complication of these necrotizing vasculitides. We describe a case of AAV who presented with acute ischemic stroke and developed multiple ICHs after administration of IV tPA. We propose that patients with AAV are more prone to develop hemorrhage in the presence of IV tPA and discuss the possible underlying pathogenesis. We suggest that AAV should be considered a contraindication for administration of IV tPA.
抗中性粒细胞胞浆抗体(ANCA)相关血管炎(AAV)是罕见疾病,其特征为坏死性小血管炎和循环ANCA,包括肉芽肿性多血管炎、显微镜下多血管炎和嗜酸性肉芽肿性多血管炎(EGPA)。急性缺血性卒中(AIS)可能是这些疾病中枢神经系统(CNS)受累的一种表现。此外,脑出血(ICH)是这些坏死性血管炎的潜在并发症。我们描述了一例AAV患者,该患者表现为急性缺血性卒中,并在静脉注射组织型纤溶酶原激活剂(IV tPA)后发生多处脑出血。我们提出,AAV患者在使用IV tPA时更易发生出血,并讨论了可能的潜在发病机制。我们建议,AAV应被视为静脉注射tPA的禁忌证。